Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autografting

High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors

Abstract

The purpose of the study was to evaluate the feasibility and safety of two cycles of high-dose chemotherapy (HDT) followed by autologous hematopoietic SCT (HSCT) in patients with poor prognosis Ewing family of tumors (EFT). Twenty patients with primary metastatic bulky disease or recurrent EFT were enrolled to a treatment protocol with two cycles of HDT and HSCT. Patients tolerated well the first (n=20) and second (n=13) cycles, with limited and predictable toxicities. Only one (5%) TRM occurred during the second cycle. Myeloid engraftment occurred at the median of 11 days after both cycles. At 3 years, the overall and EFS were 45% (confidence interval; CI 0.22, 0.69) and 47% (CI 0.25, 0.70), respectively, for the entire group and 58% (CI 0.30, 0.86) for patients who completed two cycles. Dose intensification with two cycles of HDT and HSCT is feasible and safe, with low and acceptable treatment-related morbidity and mortality. Adding a second course of therapy does not impair engraftment. However, only 65% of the patients were able to proceed to the second cycle. Further studies are required to define the optimal mode of delivery of HDT and HSCT in treatment of advanced EFT.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108–3114.

    Article  CAS  PubMed  Google Scholar 

  2. Paulussen M, Ahrens S, Craft AW, Dunst J, Frohlich B, Jabar S et al. Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 1998; 16: 3044–3052.

    Article  CAS  PubMed  Google Scholar 

  3. Cangir A, Vietti TJ, Gehan EA, Burgert Jr EO, Thomas P, Tefft M et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990; 66: 887–893.

    Article  CAS  PubMed  Google Scholar 

  4. Barker LM, Pendergrass TW, Sanders JE, Hawkins DS . Survival after recurrence of Ewing's sarcoma family of tumors. J Clin Oncol 2005; 23: 4354–4362.

    Article  PubMed  Google Scholar 

  5. Frei III E, Canellos GP . Dose: a critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–594.

    Article  PubMed  Google Scholar 

  6. Jurgens H, Exner U, Gadner H, Harms D, Michaelis J, Sauer R et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 1988; 61: 23–32.

    Article  CAS  PubMed  Google Scholar 

  7. Rosen G, Caparros B, Mosende C, McCormick B, Huvos AG, Marcove RC . Curability of Ewing's sarcoma and considerations for future therapeutic trials. Cancer 1978; 41: 888–899.

    Article  CAS  PubMed  Google Scholar 

  8. Miser JS, Kinsella TJ, Triche TJ, Tsokos M, Forquer R, Wesley R et al. Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance. J Clin Oncol 1988; 6: 484–490.

    Article  CAS  PubMed  Google Scholar 

  9. Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694–701.

    Article  CAS  PubMed  Google Scholar 

  10. Jaffe N, Paed D, Traggis D, Salian S, Cassady JR . Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy. Cancer 1976; 38: 1925–1930.

    Article  CAS  PubMed  Google Scholar 

  11. Graham-Pole J, Lazarus HM, Herzig RH, Gross S, Coccia P, Weiner R et al. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma. Am J Pediatr Hematol Oncol 1984; 6: 17–26.

    CAS  PubMed  Google Scholar 

  12. Wexler LH, Delaney TF, Tsokos M, Avila N, Steinberg SM, Weaver-McClure L et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer 1996; 78: 901–911.

    Article  CAS  PubMed  Google Scholar 

  13. Craft A, Cotterill S, Malcolm A, Spooner D, Grimer R, Souhami R et al. Ifosfamide-containing chemotherapy in Ewing's sarcoma: the second United Kingdom children's cancer study group and the medical research council Ewing's tumor study. J Clin Oncol 1998; 16: 3628–3633.

    Article  CAS  PubMed  Google Scholar 

  14. Rosito P, Mancini AF, Rondelli R, Abate ME, Pession A, Bedei L et al. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience. Cancer 1999; 86: 421–428.

    Article  CAS  PubMed  Google Scholar 

  15. Bacci G, Picci P, Ferrari S, Mercuri M, Brach dP, Rosito P et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase—results of two sequential studies. Cancer 1998; 82: 1174–1183.

    Article  CAS  PubMed  Google Scholar 

  16. Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001; 19: 1818–1829.

    Article  CAS  PubMed  Google Scholar 

  17. Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ et al. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide—a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol 2004; 22: 2873–2876.

    Article  CAS  PubMed  Google Scholar 

  18. Burdach S, Jurgens H, Peters C, Nurnberger W, Mauz-Korholz C, Korholz D et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993; 11: 1482–1488.

    Article  CAS  PubMed  Google Scholar 

  19. Miser JS, Kinsella TJ, Triche TJ, Steis R, Tsokos M, Wesley R et al. Treatment of peripheral neuroepithelioma in children and young adults. J Clin Oncol 1987; 5: 1752–1758.

    Article  CAS  PubMed  Google Scholar 

  20. Horowitz ME, Kinsella TJ, Wexler LH, Belasco J, Triche T, Tsokos M et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 1993; 11: 1911–1918.

    Article  CAS  PubMed  Google Scholar 

  21. Ladenstein R, Hartmann O, Pinkerton CR . The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood. Ann Oncol 1993; 4 (Suppl 1): 45–58.

    Article  PubMed  Google Scholar 

  22. Cornbleet MA, Corringham RE, Prentice HG, Boesen EM, McElwain TJ . Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 1981; 65: 241–244.

    CAS  PubMed  Google Scholar 

  23. Atra A, Whelan JS, Calvagna V, Shankar AG, Ashley S, Shepherd V et al. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. Bone Marrow Transplant 1997; 20: 843–846.

    Article  CAS  PubMed  Google Scholar 

  24. Pinkerton CR . Intensive chemotherapy with stem cell support-experience in pediatric solid tumours. Bull Cancer 1995; 82 (Suppl 1): 61s–65s.

    PubMed  Google Scholar 

  25. Burdach S, Meyer-Bahlburg A, Laws HJ, Haase R, van Kaik B, Metzner B et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 2003; 21: 3072–3078.

    Article  CAS  PubMed  Google Scholar 

  26. Fraser CJ, Weigel BJ, Perentesis JP, Dusenbery KE, Defor TE, Baker KS et al. Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors. Bone Marrow Transplant 2006; 37: 175–181.

    Article  CAS  PubMed  Google Scholar 

  27. Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001; 19: 2812–2820.

    Article  CAS  PubMed  Google Scholar 

  28. Gratwohl A, Baldomero H, Demirer T, Rosti G, Dini G, Ladenstein R et al. Hematopoietic stem cell transplantation for solid tumors in Europe. Ann Oncol 2004; 15: 653–660.

    Article  CAS  PubMed  Google Scholar 

  29. Michon J, Hartmann O, Demeocq F, Brunat-Mentigny M, Coze C, Boutard P et al. Consolidation with busulfan and melphalan following by blood progenitor cell (BPC) graft in children and young adults with high risk Ewing's Sarcoma: a report of the French Society of Pediatric Oncology (abstract). J Clin Oncol 1994; 13: A1415.

    Google Scholar 

  30. Diaz MA, Vicent MG, Madero L . High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors. Bone Marrow Transplant 1999; 24: 1157–1159.

    Article  CAS  PubMed  Google Scholar 

  31. Oberlin O, Rey A, Desfachelles AS, Philip T, Plantaz D, Schmitt C et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Societe Francaise des Cancers de l’Enfant. J Clin Oncol 2006; 24: 3997–4002.

    Article  CAS  PubMed  Google Scholar 

  32. Jurgens H, Exner U, Kuhl J, Ritter J, Treuner J, Weinel P et al. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma. Cancer Chemother Pharmacol 1989; 24 (Suppl 1): S40–S44.

    PubMed  Google Scholar 

  33. Grupp SA, Stern JW, Bunin N, Nancarrow C, Adams R, Gorlin JB et al. Rapid-sequence tandem transplant for children with high-risk neuroblastoma. Med Pediatr Oncol 2000; 35: 696–700.

    Article  CAS  PubMed  Google Scholar 

  34. Adams RH, Smith L, Grier HE . Rapid sequence tandem transplants for children with metastatic sarcoma. Biol Blood Marrow Transplant 2001; 7: 64 (abstract 1).

    Article  Google Scholar 

  35. Burke MJ, Walterhouse DO, Jacobsohn DA, Duerst RE, Kletzel M . Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors. Pediatr Blood Cancer 2007; 49: 196–198.

    Article  PubMed  Google Scholar 

  36. Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M et al. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 2002; 20: 2284–2292.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Rosenthal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenthal, J., Bolotin, E., Shakhnovits, M. et al. High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors. Bone Marrow Transplant 42, 311–318 (2008). https://doi.org/10.1038/bmt.2008.169

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.169

Keywords

This article is cited by

Search

Quick links